DENVER, July 1, 2025 /PRNewswire/ — TRC Healthcare, the leading provider of evidence-based medication-related resources, announced last week the launch of an upgraded NatMed Pro, the largest unbiased natural medicines database available to healthcare, research, and industry professionals. Built on trusted independent evidence—free from commercial influence—NatMed Pro delivers objective insights clinicians and researchers can trust. The redesigned platform now offers faster performance, mobile access, and seamless data integration.
Used by major health systems, regulatory agencies, and academic institutions, NatMed Pro empowers professionals with science-backed insights into the safety, efficacy, and interactions of natural medicines.
“We’ve reimagined NatMed Pro to meet the rising demand for credible, accessible information about natural therapies,” said Mikell Parsch, President, Healthcare at Colibri Group. “Clinicians can now navigate this space with greater speed, confidence, and precision.”
What’s New in NatMed Pro
Embed NatMed Pro’s API Into Your Systems for Smarter, Safer Clinical Decisions
Organizations can now access NatMed’s trusted content through an enhanced API, allowing for integration into learning management systems, clinical decision-support systems (CDSS), consumer apps, and other technology platforms.
The API provides:
Request a demo and discover how NatMed Pro can empower your team with the most trusted natural medicine insights.
About TRC Healthcare
Founded in 1985, TRC Healthcare is a leading provider of evidence-based education, training, and clinical decision support solutions that empower healthcare professionals to practice at the top of their licenses. Trusted by over one million clinicians across pharmacy, medicine, and allied health, TRC delivers unbiased, expertly curated content to enhance care quality, regulatory compliance, and professional development.
TRC Healthcare is part of Colibri Group, a professional education company helping millions of licensed professionals start and advance their careers through high-impact learning across healthcare, real estate, financial services, accounting, and more.
SOURCE TRC Healthcare
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo…
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…
Label-verified GaraHerb ingredient disclosures, manufacturing and policy transparency details, and what consumers searching for GaraHerb…
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
An informational overview examining category context, publicly available product disclosures, and what consumers often consider…